Barbara Depreter

Deciphering molecular heterogeneity in pediatric AML using a cancer vs. normal transcriptomic approach

Barbara Depreter (UGent) , Barbara De Moerloose (UGent) , Karl Vandepoele (UGent) , Anne Uyttebroeck, An Van Damme, Eva Terras (UGent) , Barbara Denys (UGent) , Laurence Dedeken, Marie-Francoise Dresse, Jutte Van der Werff Ten Bosch, et al.

(2020) PEDIATRIC RESEARCH.

Add to list

PhD Thesis

Exploring the molecular and phenotypical heterogeneity between patients with pediatric acute myeloid leukemia

Barbara Depreter (UGent)

(2020)

Add to list

Journal Article
A2
open access

Clinical significance of TARP expression in pediatric acute myeloid leukemia

Barbara Depreter (UGent) , Barbara De Moerloose (UGent) , Karl Vandepoele (UGent) , Anne Uyttebroeck, An Van Damme, Barbara Denys, Laurence Dedeken, Marie-Françoise Dresse, Jutte Van Der Werff Ten Bosch, Mattias Hofmans (UGent) , et al.

(2020) HEMASPHERE. 4(2).

Add to list

Journal Article
A1
open access

TARP is an immunotherapeutic target in acute myeloid leukemia expressed in the leukemic stem cell compartment

Barbara Depreter (UGent) , Karin Weening (UGent) , Karl Vandepoele (UGent) , Magnus Essand, Barbara De Moerloose (UGent) , Maria Themeli, Jacqueline Cloos, Diana Hanekamp, Ine Moors (UGent) , Inge D'hont (UGent) , et al.

(2020) HAEMATOLOGICA. 105(5). p.1306-1316

Add to list

Conference Paper

Long Non-Coding RNAs As Novel Therapeutic Targets in Juvenile Myelomonocytic Leukemia: Proof of Concept Study

Mattias Hofmans (UGent) , Barbara Depreter (UGent) , Tim Lammens (UGent) , Helene Cave, Christian Flotho, Henrik Hasle, Valerie de Haas, Charlotte M. Niemeyer, Jan Stary, Pieter Van Vlierberghe (UGent) , et al.

(2019) Blood. 134(Supplement_1). p.1701-1701

Add to list

Deciphering molecular heterogeneity in pediatric AML using a cancer vs normal transcriptomic approach

Barbara Depreter (UGent) , Mattias Hofmans (UGent) , Eva Terras (UGent) , Anne Uyttebroeck, An Van Damme, Alina Ferster, Jutte Van der Werff Ten Bosch, Marie-Françoise Dresse, Karl Vandepoele (UGent) , Barbara De Moerloose (UGent) , et al.

(2019) BLOOD. 134(S1). p.1457-1457

Add to list

Conference Paper
C3
open access

Deciphering molecular heterogeneity in pediatric AML using a cancer vs normal transcriptomic approach

Barbara Depreter (UGent) , Mattias Hofmans (UGent) , Eva Terras (UGent) , Anne Uyttebroeck, An Van Damme, Alina Ferster, Jutte van der Werff ten Bosch, Marie-Françoise Dresse, Karl Vandepoele (UGent) , Barbara De Moerloose (UGent) , et al.

(2019) American Society of Hematology, 61st Annual meeting, Abstracts.

Add to list

Conference Paper
C3
open access

TARP as immunotherapeutic target in AML expressed in the LSC compartment

Barbara Depreter (UGent) , Karin Weening (UGent) , Karl Vandepoele (UGent) , M Essand, Barbara De Moerloose (UGent) , M Themeli, J Cloos, D Hanekamp, Ine Moors (UGent) , Inge D'hont (UGent) , et al.

(2019) HEMASPHERE. 3(suppl. 1). p.54-54

Add to list

Leukaemic stem cell load at diagnosis predicts the development of relapse in young acute myeloid leukaemia patients

Diana Hanekamp, Barbara Denys (UGent) , Gertjan JL Kaspers, Jeroen G te Marvelde, Gerrit Jan Schuurhuis, Valerie De Haas, Barbara De Moerloose (UGent) , Eveline S de Bont, C Michel Zwaan, Anja de Jong, et al.

(2018) BRITISH JOURNAL OF HAEMATOLOGY. 183(3). p.512-516

Add to list

Cancer-related mRNA expression analysis using a novel flow cytometry-based assay

Barbara Depreter (UGent) , Jan Philippé (UGent) , MAGALI MEUL (UGent) , Barbara Denys (UGent) , Karl Vandepoele (UGent) , Barbara De Moerloose (UGent) and Tim Lammens (UGent)

(2018) CYTOMETRY PART B-CLINICAL CYTOMETRY. 94(4). p.565-575

Academic Bibliography

Barbara Depreter

Deciphering molecular heterogeneity in pediatric AML using a cancer vs. normal transcriptomic approach

Exploring the molecular and phenotypical heterogeneity between patients with pediatric acute myeloid leukemia

Clinical significance of TARP expression in pediatric acute myeloid leukemia

TARP is an immunotherapeutic target in acute myeloid leukemia expressed in the leukemic stem cell compartment

Long Non-Coding RNAs As Novel Therapeutic Targets in Juvenile Myelomonocytic Leukemia: Proof of Concept Study

Deciphering molecular heterogeneity in pediatric AML using a cancer vs normal transcriptomic approach

Deciphering molecular heterogeneity in pediatric AML using a cancer vs normal transcriptomic approach

TARP as immunotherapeutic target in AML expressed in the LSC compartment

Leukaemic stem cell load at diagnosis predicts the development of relapse in young acute myeloid leukaemia patients

Cancer-related mRNA expression analysis using a novel flow cytometry-based assay

Contents

Support

Contact